Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -2.66
- Piotroski Score 3.00
- Grade N/A
- Symbol (CEI)
- Company Camber Energy, Inc.
- Price $0.10
- Changes Percentage (-6.1%)
- Change -$0.01
- Day Low $0.10
- Day High $0.11
- Year High $0.58
Camber Energy, Inc., an independent oil and natural gas company, engages in the acquisition, development, and sale of crude oil, natural gas, and natural gas liquids (NGL) in Kansas, Missouri; Louisiana; and Texas. As of December 31, 2021, its total estimated proved producing reserves consists of approximately 73,800 barrels of oil equivalent, including 48,400 barrels were crude oil and NGL reserves, and 152,400 thousand cubic feet were natural gas reserves. The company was formerly known as Lucas Energy Inc. and changed its name to Camber Energy, Inc. in January 2017. Camber Energy, Inc. was incorporated in 2003 and is headquartered in Houston, Texas.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/14/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.62
- Trailing P/E Ratio -0.24
- Forward P/E Ratio -0.24
- P/E Growth -0.24
- Net Income $-32,649,965
Income Statement
Quarterly
Annual
Latest News of CEI
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Recce Pharmaceuticals receives approval for Phase III DFI trial in Indonesia
Recce Pharmaceuticals has received approval for a Phase III trial of RECCE 327 (R327G) in Indonesia for diabetic foot infections. The study aims to enroll 300 patients, with results expected by the en...
By Yahoo! Finance | 1 day ago -
Japan's Seven & i says receives buyout proposal from founding Ito family
By Ritsuko Shimizu and Kane WuTOKYO (Reuters) -Japan's Seven & i Holdings has received a buyout proposal from a member of its founding Ito family, it said on Wednesday following a report that the ...
By Reuters | 1 day ago -
NYC homeowner says ceiling collapsed months after solar panel installation
A homeowner in New York City installed solar panels to reduce electricity costs but ended up losing thousands of dollars. Investigative reporter Mahsa Saeidi explores how to benefit from solar power w...
By CBS News | 1 day ago
